Cardiology
Conference Coverage
‘Game changer’ semaglutide halves diabetes risk from obesity
Post-hoc analysis of two semaglutide trials in people with obesity showed treatment cut their projected 10-year risk for incident type 2 diabetes...
From the Journals
New science reveals the best way to take a pill
Posture determined as much as 83% of how quickly a pill disperses into the intestines.
Feature
Two states aim to curb diet pill sales to minors
California and New York are on the cusp of going further than the FDA in restricting the sale of nonprescription diet pills to minors as...
Latest News
Your poop may hold the secret to long life
If we could pull off a banking system like this, it could have the potential to treat autoimmune disease, inflammatory bowel disease, diabetes,...
Conference Coverage
Heparin pretreatment may safely open arteries before STEMI cath
The “early reperfusion” associated with IRA patency at angiography “could have long-term benefit due to smaller infarct size.”
Conference Coverage
Myocardial infarction in women younger than 50: Lessons to learn
“Cardiovascular disease is the main cause of death in women, killing seven times more than breast cancer,” notes Dr. Manzo-Silberman.
Conference Coverage
Dietary change tops for reducing CVD risk in stage 1 hypertension
Healthy lifestyle changes, particularly adoption of the DASH diet, can reduce CVD events in people with stage 1 hypertension.
From the Journals
Lack of exercise linked to small heart, HFpEF
Chronic “exercise deficiency” is a major risk factor for heart failure with preserved ejection fraction, and regular physical activity ... may...
From the Journals
Even mild COVID tied to vascular impairment
“It may encourage treating clinicians to be more aggressive with preventative neurovascular and cardiovascular health measures and/or screening in...
Feature
How does salt intake relate to mortality?
Although there is an ongoing debate about the extent of salt’s effects ... there is no doubt that in most places in the world, people are...
Conference Coverage
No invasive strategy benefit at 5 years in ISCHEMIA-CKD extension study
The trial speaks to the lofty high-risk status of patients with CAD. ‘You’re seeing in a group of patients, with largely preserved EF but advanced...